Deepflare
Recent Finacing
Pre-Seed
Recent Raise
$1.5M
Deepflare develops AI and ML models and genomic analysis tools to accelerate mRNA vaccine and antiviral drug development and previously provided large-scale SARS‑CoV‑2 sequencing analysis in Poland.
Highlights
Focus Areas
Artificial Intelligence (AI)
Biotechnology
Recent Investors
Financials
$1.5M
Total Raised
1
Funding round
2
Investors